Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Rubinstein Julie sold 19,037 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Apr 27, 2026 · Filed Apr 29, 2026
On Apr 27, 2026, Rubinstein Julie (President and COO) sold 19,037 Adaptive Biotechnologies Corporation shares at US$14.23 for US$271K under a trading plan, leaving 377,802 shares. Filed Apr 29, 2026 (Form 4).
- Sold
- 19,037 shares
- Price
- US$14.23
- Value
- US$271K
- Holding after
- 377,802 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | Option exercise | 14,707 | US$8.46 | 396,839 | Direct |
| Apr 27, 2026 | Common Stock | Sale | 19,037 | US$14.23 | 377,802 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Rubinstein Julie
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Rubinstein Julie · Oct 21, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Lo Francis · Oct 5, 2026
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026